The association between osteoprotegerin and arterial stiffness in a 10-year longitudinal study of patients with type 2 diabetes
Diabetes and Vascular Disease Research · 2024
DOI: 10.1177/14791641241304435 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes and Vascular Disease Research, 2024. Verfasst von Serena Low und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Unit, Khoo Teck Puat Hospital, Singapore, Singapore. Hauptthemen laut MEDLINE: Osteoprotegerin, Diabetes Mellitus, Type 2, Vascular Stiffness, Vascular Cell Adhesion Molecule-1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Medical Research Council.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Osteoprotegerin (OPG) inhibits vascular calcification which is central to pathogenesis of arterial stiffness. However, it promotes inflammation by upregulating expression of vascular cell adhesion molecule-1(VCAM-1), thereby contributing to arterial stiffness. We investigated longitudinal association between OPG and arterial stiffness in type 2 diabetes (T2D), causality of the association and mediation by VCAM-1.
Methods
This was a prospective cohort study of T2D patients ( N = 1877, mean age 57.0 ± 10.8) with 10 years’ follow-up. Baseline plasma OPG was measured using immunoassay. Pulse wave velocity (PWV) was assessed using applanation tonometry. We examined association between OPG and follow-up PWV using linear mixed model. One-sample Mendelian Randomization (MR) was conducted with rs1385492 as OPG-associated single nucleotide polymorphism (SNP).
Results
Baseline natural log (Ln)-transformed OPG was positively associated with baseline and follow-up PWV with adjusted coefficients 0.43 (95%CI 0.05, 0.80; p = .026) and 0.51 (95%CI 0.06 to 0.97; p = .028) respectively. Genetically-predicted higher levels of plasma OPG was associated with higher last follow-up PWV with coefficient 10.81 (95%CI 2.97, 18.65; p = .007) per unit increase in LnOPG. Higher VCAM-1 accounted for 10.2% of association between LnOPG and follow-up PWV.
Discussion
Baseline plasma OPG was associated with higher follow-up PWV in patients with T2D, with genetic evidence from MR. This association may be mediated, at least in part, by VCAM-1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research Unit, Khoo Teck Puat Hospital, Singapore, Singapore.
- Diabetes Centre, Admiralty Medical Centre, Singapore, Singapore.
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
- National Healthcare Group Polyclinics, Singapore, Singapore.
- Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
ORCID-Profile: Tavintharan Subramaniam, Su Chi Lim
Förderung
- National Medical Research Council
Zitieren
APA
Low, S., Pek, S., Moh, A., Liu, J. J., Pandian, B., Ang, K., Tang, W. E., Lim, Z., Subramaniam, T., Sum, C. F., & Lim, S. C. (2024). The association between osteoprotegerin and arterial stiffness in a 10-year longitudinal study of patients with type 2 diabetes. Diabetes and Vascular Disease Research. https://doi.org/10.1177/14791641241304435
Vancouver
Low S, Pek S, Moh A, Liu JJ, Pandian B, Ang K, et al. The association between osteoprotegerin and arterial stiffness in a 10-year longitudinal study of patients with type 2 diabetes. Diabetes and Vascular Disease Research. 2024. doi:10.1177/14791641241304435
BibTeX
@article{Low2024,
author = {Low, Serena and Pek, Sharon and Moh, Angela and Liu, Jian-Jun and Pandian, Bhuvaneswari and Ang, Keven and Tang, Wern Ee and Lim, Ziliang and Subramaniam, Tavintharan and Sum, Chee Fang and Lim, Su Chi},
title = {The association between osteoprotegerin and arterial stiffness in a 10-year longitudinal study of patients with type 2 diabetes},
journal = {Diabetes and Vascular Disease Research},
year = {2024},
doi = {10.1177/14791641241304435}
}
EUVIMED